We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 46

Canadian privacy commissioners release guidance on workplace H1N1 privacy

  • Torys LLP
  • -
  • Canada
  • -
  • November 18 2009

On October 29, 2009 the Office of the Privacy Commissioner of Canada (OPC), together with the Privacy Commissioners’ offices of Alberta and British Columbia, published a guidance document titled "Privacy in the Time of a Pandemic: Guidance for Organizations."

Follow-on biologics in Canada: a look at the new draft guidelines

  • Torys LLP
  • -
  • Canada
  • -
  • May 27 2008

Health Canada has released a draft guidance document entitled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).”

Health Canada announces intent to develop a framework for orphan drug approval

  • Torys LLP
  • -
  • Canada, USA
  • -
  • October 5 2012

On October 3, 2012, Health Canada issued a press release announcing that it will develop a framework for the marketing approval of drugs to treat rare life-threatening, seriously debilitating or serious chronic rare diseases that are commonly referred to as "orphan drugs."

Producers to manage pharmaceuticals and sharps returned by consumers

  • Torys LLP
  • -
  • Canada
  • -
  • November 2 2012

On October 1, 2012, Collection of Pharmaceuticals and Sharps Responsibilities of Producers regulation (O. Reg. 29812) came into force

Canada amends regulations on adverse drug reaction reporting

  • Torys LLP
  • -
  • Canada
  • -
  • March 11 2011

Amended regulations regarding the reporting of adverse drug reactions came into force on February 10, 2011

Ontario case on product liability shows the immense scope of a class action trial

  • Torys LLP
  • -
  • Canada
  • -
  • July 5 2012

In a highly anticipated decision released on June 26, 2012, the Ontario Superior Court of Justice ruled in favour of the defendants in Andersen v. St. Jude Medical, Inc., Ontario’s first medical product liability class action trial

Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations

  • Torys LLP
  • -
  • Canada
  • -
  • April 29 2008

On April 26, 2008, the government of Canada published for comment proposed amendments to the Patented Medicines (Notice of Compliance) Regulations, commonly referred to as the “PM(NOC) Regulations.”

Canada’s PAAB releases updated Code of Advertising Acceptance

  • Torys LLP
  • -
  • Canada
  • -
  • December 7 2012

The Pharmaceutical Advertising Advisory Board (PAAB) has released a revised version of its Code of Advertising Acceptance

Innovative drugs sold under the special access programme can receive data protection in Canada

  • Torys LLP
  • -
  • Canada
  • -
  • May 18 2011

To benefit from data protection in Canada, a drug must meet the definition of "innovative drug" under the Food and Drug Regulations

Ontario drug system reform

  • Torys LLP
  • -
  • Canada
  • -
  • April 12 2010

The Ontario government has published proposed regulatory changes under the Ontario Drug Benefit Act and the Drug Interchangeability and Dispensing Fee Act (DIDFA) that will affect the prices paid for generic drugs in both the public and private sector